HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raymond M Reilly Selected Research

Doxorubicin (Adriamycin)

3/2014Intracellular routing in breast cancer cells of streptavidin-conjugated trastuzumab Fab fragments linked to biotinylated doxorubicin-functionalized metal chelating polymers.
3/2010Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raymond M Reilly Research Topics

Disease

84Neoplasms (Cancer)
05/2024 - 12/2002
72Breast Neoplasms (Breast Cancer)
05/2024 - 09/2003
12Body Weight (Weight, Body)
10/2022 - 09/2003
7Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 09/2005
6Pancreatic Neoplasms (Pancreatic Cancer)
11/2020 - 02/2015
6Leukemia
10/2016 - 09/2011
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2018 - 05/2006
4Triple Negative Breast Neoplasms
12/2023 - 01/2020
4Brain Neoplasms (Brain Tumor)
09/2023 - 10/2011
3Carcinoma (Carcinomatosis)
05/2024 - 07/2013
3Infertility (Sterility)
12/2022 - 04/2004
3Myeloid Leukemia (Leukemia, Myelocytic)
05/2014 - 05/2006
2Glioblastoma (Glioblastoma Multiforme)
01/2023 - 10/2005
2Inflammation (Inflammations)
10/2011 - 09/2005
1Adenocarcinoma
07/2023
1Central Nervous System Diseases (CNS Diseases)
10/2021
1Squamous Cell Carcinoma of Head and Neck
08/2021
1Chromosome Aberrations (Chromosome Abnormalities)
10/2019
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
10/2016

Drug/Important Bio-Agent (IBA)

41Trastuzumab (Herceptin)FDA Link
05/2024 - 01/2005
28Epidermal Growth Factor (EGF)IBA
05/2024 - 12/2002
21Immunoconjugates (Immunoconjugate)IBA
05/2024 - 03/2006
16Monoclonal AntibodiesIBA
10/2021 - 05/2006
14Immunoglobulin G (IgG)IBA
12/2023 - 12/2002
14Peptides (Polypeptides)IBA
01/2021 - 03/2006
13GoldIBA
05/2024 - 12/2010
13Pentetic Acid (DTPA)FDA LinkGeneric
01/2020 - 04/2004
12Panitumumab (Vectibix)FDA Link
05/2024 - 02/2015
11ErbB Receptors (EGF Receptor)IBA
10/2022 - 09/2003
10PolymersIBA
01/2019 - 05/2012
10Immunoglobulin Fab FragmentsIBA
11/2015 - 01/2005
9Radioisotopes (Radionuclides)IBA
05/2024 - 05/2005
9MetalsIBA
01/2019 - 10/2005
8MicellesIBA
05/2024 - 09/2007
81,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
12/2023 - 02/2012
8RadiopharmaceuticalsIBA
12/2022 - 09/2003
8Proteins (Proteins, Gene)FDA Link
12/2022 - 04/2004
8Saline SolutionIBA
10/2022 - 09/2003
8CreatinineIBA
11/2020 - 09/2003
7Alanine Transaminase (SGPT)IBA
11/2020 - 09/2003
7AcidsIBA
12/2016 - 09/2003
5pertuzumabIBA
01/2021 - 08/2009
5Chelating AgentsIBA
01/2019 - 10/2005
5EpitopesIBA
11/2014 - 03/2006
4Nuclear Localization Signals (Nuclear Localization Signal)IBA
12/2022 - 08/2012
4Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2022 - 04/2016
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2007 - 09/2005
31,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
05/2024 - 05/2020
3neodymium pyrocatechin disulfonate (NPD)IBA
11/2022 - 12/2016
3AntibodiesIBA
11/2022 - 09/2006
3His-His-His-His-His-His ((His)6)IBA
01/2021 - 05/2007
3Ado-Trastuzumab EmtansineIBA
05/2020 - 01/2018
3nimotuzumabIBA
01/2020 - 08/2012
3DNA (Deoxyribonucleic Acid)IBA
10/2019 - 03/2009
3Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
10/2018 - 09/2011
3StreptavidinIBA
11/2015 - 01/2013
3LigandsIBA
01/2013 - 09/2007
2Dendrimers (Dendrons)IBA
05/2024 - 08/2013
2Liposomes (Liposome)IBA
05/2024 - 11/2017
2human ERBB2 proteinIBA
11/2015 - 12/2012
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2014 - 03/2010
2Hormones (Hormone)IBA
01/2013 - 09/2003
2scyllitol (scyllo-inositol)IBA
10/2011 - 10/2009
2Hemoglobins (Hemoglobin)IBA
07/2010 - 09/2003
2hippuryl-glycyl-glycine (HIGG)IBA
07/2010 - 08/2009
2Methotrexate (Mexate)FDA LinkGeneric
03/2010 - 09/2008
2Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2009 - 09/2006
2111In-DTPA-human epidermal growth factorIBA
08/2008 - 06/2006
2Messenger RNA (mRNA)IBA
02/2008 - 09/2003
2Tumor Viral Antigens (Large T Antigen)IBA
08/2007 - 05/2006
2Cyclin-Dependent Kinase Inhibitor p21IBA
03/2007 - 09/2006
2tat Gene Products (tat Protein)IBA
01/2007 - 09/2006
2WK-X-34IBA
11/2006 - 07/2006
1CelluloseIBA
05/2024
1Carbon Nanotubes (Carbon Nanotube)IBA
05/2024
1Growth Factor ReceptorsIBA
12/2023
1EndotoxinsIBA
12/2022
1Therapeutic UsesIBA
11/2022
1POEGMAIBA
01/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2020
1rucaparibIBA
05/2020
1GemcitabineFDA Link
05/2020
1SuspensionsIBA
10/2017
1AntigensIBA
01/2017
1Indicators and Reagents (Reagents)IBA
01/2015
1CSL360IBA
11/2014
12- (1- hydroxyundecyl)- 1- (4- nitrophenylamino)- 6- phenyl- 6,7a- dihydro- 1H- pyrrolo(3,4- b)pyridine- 5,7(2H,4aH)- dioneIBA
05/2014
1Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA
05/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
05/2014
1ChromatinIBA
03/2014
1butyl phosphorotrithioate (DEF)IBA
11/2013

Therapy/Procedure

18Therapeutics
05/2024 - 09/2006
17Radioimmunotherapy
12/2023 - 02/2006
12Radiotherapy
01/2020 - 05/2007
8Precision Medicine
09/2023 - 11/2014
3Brachytherapy
11/2022 - 01/2016
2Injections
08/2012 - 09/2004
1Immunotherapy
11/2022
1Neoadjuvant Therapy
01/2016
1Aftercare (After-Treatment)
05/2014